Clinical and biological abnormalities in patients after fasciolosis treatment.
OBJECTIVE
The aim of this communication was to report clinical disorders and biological abnormalities in patients followed over a 3- to 18-year period after the last date of fasciolosis treatment. These observations were noted in 87 individuals (out of 711) during a 30-year epidemiological survey.


RESULTS
We noted diffuse pain in the right hypochondrium, persisting 2 to 6 years after treatment (3.7% of persons), and weight loss appearing during treatment and persisting afterwards (2.1%).


CONCLUSIONS
Our current state of knowledge leads us to asking whether pain in the right hypochondrium and weight loss would not be due to the presence of persistent hepatic lesions following fasciolosis treatment. Other investigations in patients after treated fasciolosis are necessary to confirm these abnormalities and determine their frequency.
Rondelaud
D
D
UPRES EA n(o) 3174/USC Inra, Facultés de Médecine et de Pharmacie, 87025 Limoges, France. daniel.rondelaud@unilim.fr <daniel.rondelaud@unilim.fr>
Dreyfuss
G
G
Vignoles
P
P
D000818:Animals; D001247:Asthenia / Q000453:epidemiology; D003244:Consciousness Disorders / Q000453:epidemiology; D004784:Environmental Monitoring; D016021:Epidemiologic Studies; D062665:Epidemiological Monitoring; D005209:Fasciola; D005211:Fascioliasis / Q000150:complications* / Q000453:epidemiology; D005243:Feces / Q000469:parasitology; D005500:Follow-Up Studies; D005602:France / Q000453:epidemiology; D006801:Humans; D010270:Parasite Egg Count; D014201:Trematode Infections / Q000150:complications* / Q000453:epidemiology; D015431:Weight Loss